Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

20 Mar 2007 07:00

Embargoed Release: 07:00hrs Tuesday 20th March 2007

Sopheon plc (`Sopheon') Land O'Lakes to Deploy Sopheon's Product Life Cycle Management Solution

Leading Consumer Goods Company Adopts Accolade‚® to Automate Stage-Gate‚® Process

and Support Focus on High-Value Products

Sopheon, the international software and services company, announces today that Land O'Lakes, Inc., a leading dairy co-operative, is implementing Sopheon's Accolade product life cycle management (`PLM') system as the technology foundation for its product innovation processes. The solution will be used initially within the company's Dairy Foods business unit, where it will support cross-functional teams responsible for developing and commercializing new products. Plans include subsequent enterprise-wide deployment.

Headquartered in St. Paul, Minn., Land O'Lakes generates annual revenues of more than $7 billion and is one of the largest dairy co-ops in the U.S. It markets milk, spreads, cheeses and deli products to consumers, food services and food manufacturers throughout the world.

Land O'Lakes also offers an extensive line of agricultural supplies and state-of-the-art production, distribution and business services. During its 86-year history, the company has established a reputation for quality, strong brands and innovation.

Land O'Lakes has stated that one of its principal strategic goals is to incorporate best practices into all aspects of its operations. This focus is part of an overarching plan to drive additional revenues and profit growth from the company's core businesses. Actions include an initiative aimed at enhancing the process for product innovation.

Sopheon's system will be used to automate the Stage-Gate product development methodology being deployed by Land O'Lakes. Accolade will streamline the innovation process, making it easier to use and reducing the administrative burden otherwise associated with its implementation. Step-by-step task guidelines and Land O'Lakes' best-practice based report templates have been embedded in the software to support efficient process execution and successful completion of deliverables. The system will strengthen innovation process governance by providing decision support and controls that enable more informed prioritization of product development projects.

"Innovation is essential to our business success," said Tom Grueztmacher, vice-president of research and development at Land O'Lakes. "Accolade will automate our product development process and assist us in setting project priorities. Its capabilities will help to ensure that the right new products get to market, and get there on time. In designing our system we benefited from Sopheon's domain expertise in product-development best practices and the fact that they have installed and supported similar, successful systems for a substantial number of consumer packaged goods (CPG) companies. Their industry-specific know-how gave us an important leg up in developing a process in which we can have confidence."

"Business process improvement is a central strategic thrust for most companies today," said Andy Michuda, CEO of Sopheon. "And recent surveys consistently place product and service development processes among the top improvement priorities. The reasons are all about business. Improved innovation means substantial increases in portfolio net-present-value and, ultimately, higher profits, revenues and stakeholder returns. Land O'Lakes' aim is to compete not only with superior products, but also with superior product development processes. We are committed to helping them achieve that goal."

Land O'Lakes' deployment continues an extended pattern of Accolade adoption by major consumer goods manufacturers. Ten of the 100 companies comprising Consumer Goods Technology magazine's current registry of the world's largest consumer goods producers are using the Sopheon system. Examples include Cadbury Schweppes, Electrolux, Nestle, and Reckitt Benckiser.

-Ends-

Accolade‚® is a registered trademark of Sopheon plc.

Stage-Gate‚® is a registered trademark of the Product Development Institute.

All other trademarks and registered trademarks are the sole

property of their respective owners.

About Land O'Lakes

Land O'Lakes, Inc. is a farmer-owned food and agricultural cooperative with annual sales of more than $7 billion. Land O'Lakes does business in all 50 states and more than 50 countries. It is a leading marketer of a full line of dairy-based consumer, foodservice and food ingredient products across the United States; serves its international customers with a variety of food and animal feed ingredients; and provides farmers and ranchers with an extensive line of agricultural supplies (feed, seed, crop nutrients and crop protection products) and services. Land O'Lakes also provides agricultural assistance and technical training in more than 25 developing nations. For more information, please visit www.landolakesinc.com.

About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010

SOPHEON PLC
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.